Company intelligence
Novalix
Novalix is a premier drug discovery CRO
About Novalix
Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com
Verified activity
Signals from Novalix
8 published signals
Presence & Recognition
Novalix is attending the 14th Symposium on DNA-Encoded Chemical Libraries in Zurich, Switzerland from September 10 to 11.
Reported by Novalix
Presence & Recognition
Novalix is hosting a booth at Novalix Booth 30 featuring partners Chemspeed and SciY discussing Structural Biology challenges, High Throughput Experimentation in chemistry, and Lab Automation.
Reported by Sascha Hartmann
Research & Knowledge
Novalix provides advanced research tools, including disease models that mimic human PKD, to support the mission of PKD awareness and research.
Reported by Novalix
Research & Knowledge
Novalix celebrated the determination of the highest-resolution protein structure reported to date at 0.43 Å by Ashwin Chari and collaborators.
Reported by Novalix
Presence & Recognition
Novalix is hosting a meeting with a strong team including founders to discuss drug discovery science, trends, and challenges.
Reported by Sascha Hartmann
Presence & Recognition
Novalix is exhibiting at the EFMC 2026 conference in Basel, Switzerland, booth No. 30, presenting an oral communication on Discovery of Novel METTL3 Inhibitors for the Treatment of Cancer and a workshop on From Bench to Automation.
Reported by Novalix
Presence & Recognition
Novalix co-exhibits with partners SciY and contributes to the scientific programme via Laurence MEVELLEC and Matthieu JEANTY in the joint workshop presentation on From Bench to Automation.
Reported by Sascha Hartmann
Operations & Supply
Novalix shared site visits and conversations with colleagues in Romainville, Paris and Val de Reuil, Normandie.
Reported by Sascha Hartmann